Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11


Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies.

Phipps AI, Alwers E, Harrison T, Banbury B, Brenner H, Campbell PT, Chang-Claude J, Buchanan D, Chan AT, Farris AB, Figueiredo JC, Gallinger S, Giles GG, Jenkins M, Milne RL, Newcomb PA, Slattery ML, Song M, Ogino S, Zaidi SH, Hoffmeister M, Peters U.

Gastroenterology. 2020 Feb 20. pii: S0016-5085(20)30240-7. doi: 10.1053/j.gastro.2020.02.029. [Epub ahead of print]


Postmenopausal hormone replacement therapy and colorectal cancer risk by molecular subtypes and pathways.

Amitay EL, Carr PR, Jansen L, Alwers E, Roth W, Herpel E, Kloor M, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M.

Int J Cancer. 2020 Jan 14. doi: 10.1002/ijc.32868. [Epub ahead of print]


Association of BMI and major molecular pathological markers of colorectal cancer in men and women.

Carr PR, Amitay EL, Jansen L, Alwers E, Roth W, Herpel E, Kloor M, Schneider M, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M.

Am J Clin Nutr. 2020 Jan 3. pii: nqz315. doi: 10.1093/ajcn/nqz315. [Epub ahead of print]


Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study.

Alwers E, Jansen L, Bläker H, Kloor M, Tagscherer KE, Roth W, Boakye D, Herpel E, Grüllich C, Chang-Claude J, Brenner H, Hoffmeister M.

Mol Oncol. 2020 Feb;14(2):363-372. doi: 10.1002/1878-0261.12611. Epub 2020 Jan 7.


Identification of prognostic DNA methylation biomarkers in patients with gastrointestinal adenocarcinomas: A systematic review of epigenome-wide studies.

d'Errico M, Alwers E, Zhang Y, Edelmann D, Brenner H, Hoffmeister M.

Cancer Treat Rev. 2020 Jan;82:101933. doi: 10.1016/j.ctrv.2019.101933. Epub 2019 Nov 23.


External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS.

Alwers E, Bläker H, Walter V, Jansen L, Kloor M, Arnold A, Sieber-Frank J, Herpel E, Tagscherer KE, Roth W, Chang-Claude J, Brenner H, Hoffmeister M.

BMC Cancer. 2019 Jul 11;19(1):681. doi: 10.1186/s12885-019-5842-7.


Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancer.

Neumeyer S, Popanda O, Edelmann D, Butterbach K, Toth C, Roth W, Bläker H, Jiang R, Herpel E, Jäkel C, Schmezer P, Jansen L, Alwers E, Benner A, Burwinkel B, Hoffmeister M, Brenner H, Chang-Claude J.

Epigenetics. 2019 May;14(5):477-493. doi: 10.1080/15592294.2019.1595998. Epub 2019 Mar 30.


The Association Between Mutations in BRAF and Colorectal Cancer-Specific Survival Depends on Microsatellite Status and Tumor Stage.

Bläker H, Alwers E, Arnold A, Herpel E, Tagscherer KE, Roth W, Jansen L, Walter V, Kloor M, Chang-Claude J, Brenner H, Hoffmeister M.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):455-462.e6. doi: 10.1016/j.cgh.2018.04.015. Epub 2018 Apr 13.


Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analyses.

Carr PR, Alwers E, Bienert S, Weberpals J, Kloor M, Brenner H, Hoffmeister M.

Ann Oncol. 2018 Apr 1;29(4):825-834. doi: 10.1093/annonc/mdy059.


Associations Between Molecular Classifications of Colorectal Cancer and Patient Survival: A Systematic Review.

Alwers E, Jia M, Kloor M, Bläker H, Brenner H, Hoffmeister M.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):402-410.e2. doi: 10.1016/j.cgh.2017.12.038. Epub 2018 Jan 3. Review.


High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer.

Cendales R, Alwers E, Cifuentes J, Bobadilla I, Torres F, Arbelaez J, Gaitan A, Cortes H, Acevedo Y, Quintero P, Vasquez J.

J Contemp Brachytherapy. 2015 Feb;7(1):10-6. doi: 10.5114/jcb.2015.48838. Epub 2015 Feb 4.

Supplemental Content

Loading ...
Support Center